Canada markets open in 8 hours 1 minute

NLS Pharmaceutics AG (NLSP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7700+0.0791 (+11.45%)
At close: 03:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 24.97M
Enterprise Value 23.97M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)7.61
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.46

Trading Information

Stock Price History

Beta (5Y Monthly) -0.82
52-Week Change 3-1.41%
S&P500 52-Week Change 313.11%
52 Week High 31.8800
52 Week Low 30.4200
50-Day Moving Average 30.8763
200-Day Moving Average 31.1828

Share Statistics

Avg Vol (3 month) 3133.63k
Avg Vol (10 day) 347.74k
Shares Outstanding 532.43M
Implied Shares Outstanding 632.43M
Float 814.18M
% Held by Insiders 138.48%
% Held by Institutions 119.94%
Shares Short (Sept 14, 2023) 4158.62k
Short Ratio (Sept 14, 2023) 41.42
Short % of Float (Sept 14, 2023) 40.74%
Short % of Shares Outstanding (Sept 14, 2023) 40.49%
Shares Short (prior month Aug 14, 2023) 485.75k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Dec 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-128.66%
Return on Equity (ttm)-862.92%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -15.47M
Net Income Avi to Common (ttm)-16.5M
Diluted EPS (ttm)-0.7700
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.95M
Total Cash Per Share (mrq)0.28
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.75
Book Value Per Share (mrq)0.10

Cash Flow Statement

Operating Cash Flow (ttm)-13.88M
Levered Free Cash Flow (ttm)-8.69M